Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach
Despite progress in reducing hepatitis B and C infections in Europe, the region is unlikely to meet the 2030 elimination targets due to inconsistent implementation of prevention measures. While childhood vaccination and screening have improved, gaps remain in broader public health strategies.
Why it matters
The failure to meet these targets poses a continued public health threat, highlighting the need for more uniform health policy across European nations.
by European Centre for Disease Prevention and Control (ECDC)
edited by Sadie Harley , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: Pixabay/CC0 Public Domain While Europe has made steady progress in preventing hepatitis B and C, with the prevalence of hepatitis B now at near-zero levels among children younger than 5, uneven implementation of key measures means the region is set to miss the 2030 target to eliminate viral hepatitis as a public health threat, according to new data from the European Center for Disease Prevention and Control (ECDC) on World Hepatitis Day.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in